Immune Checkpoint Inhibitors Global Market Report 2022: Rising Prevalence of Cancer Boosts Sector Growth - ResearchAndMarkets.com
Immune checkpoint inhibitors are a part of immuno-oncology therapies, which involves use of patients' immune system to fight against cancer.
- Immune checkpoint inhibitors are a part of immuno-oncology therapies, which involves use of patients' immune system to fight against cancer.
- Immune checkpoint inhibitors are immunotherapy products that block the proteins, which stop immune system from attacking the cancer cells.
- Immune checkpoint inhibitors work against a wide variety of cancer, which include non-small cell lung cancer, lymphoma, skin cancer, breast cancer, and others.
- The rise in prevalence of cancer is expected to drive the global immune checkpoint inhibitors market.